Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
national top stories
third rock ventures
6
×
biotech
boston blog main
boston top stories
boston
cancer
new york blog main
san francisco blog main
san francisco top stories
amgen
biogen
cancer drugs
gene therapy
investing
ipo
new york top stories
revolution medicines
roche
san francisco
sanofi
startups
the column group
venture capital
warp drive bio
acadia pharmaceuticals
adeno-associated virus
adverum biotechnologies
aimmune
alk
ally bridge group
antisense oligonucleotide
avalon ventures
aveo oncology
benzodiazepines
big data analytics
blackrock
What
medicines
cancer
drug
ipo
research
bio
drugs
genetic
new
proteins
revolution
adding
advanced
ago
aiming
aims
analysis
arrival
award
backed
balance
biotech
bring
build
cancer’s
cause
ceo
company
data
death
decades
decibel
dems
despite
develop
disease
diseases
emerged
employing
epilepsy
Language
unset
6
×
Current search:
unset
×
" third rock ventures "
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More